A carregar...
Lipid Lowering Therapy and Circulating PCSK9 Concentration
Hypercholesterolemia, particularly an increase in low-density lipoprotein cholesterol (LDL-C) levels, contributes substantially to the development of coronary artery disease and the risk for cardiovascular events. As the first-line pharmacotherapy, statins have been shown to reduce both LDL-C levels...
Na minha lista:
| Publicado no: | J Atheroscler Thromb |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Japan Atherosclerosis Society
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5587514/ https://ncbi.nlm.nih.gov/pubmed/28804094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|